Jonathan G Drachman's Net Worth

-$450 Thousand

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Jonathan G Drachman?

Jonathan G Drachman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, Calithera Biosciences, Inc., AQUINOX PHARMACEUTICALS, INC, and Harpoon Therapeutics, Inc..

SEC CIK

Jonathan G Drachman's CIK is 0001588467

Past Insider Trading and Trends

2019 was Jonathan G Drachman's most active year for acquiring shares with 13 total transactions. Jonathan G Drachman's most active month to acquire stocks was the month of July. 2017 was Jonathan G Drachman's most active year for disposing of shares, totalling 12 transactions. Jonathan G Drachman's most active month to dispose stocks was the month of February. 2019 saw Jonathan G Drachman paying a total of $1,781,741.38 for 4,228,591 shares, this is the most they've acquired in one year. In 2017 Jonathan G Drachman cashed out on 91,318 shares for a total of $2,068,032.04, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SEATTLE GENETICS INC /WA (SGEN) No price found

See Remarks

Jonathan G Drachman owns 201,973 units of Common Stock. In the year 2013 Jonathan G Drachman filed a total of 23 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 20
Form 4
+18.16%
31.04K
$14.15
$439,134.38
201.97K
Mar 20
Form 4
—
0
$30.90
-$458,757.12
170.93K
Scheduled
Mar 5
Form 4
+12.81%
19.42K
$11.06
$214,705.16
170.93K
Jan 11
Form 4
+13.33%
17.82K
$11.52
$205,252.93
151.52K
Oct 5
Form 4
-5.98%
-8.50K
$47.89
-$407,199.04
133.7K
Scheduled
Aug 28
Form 4
—
0
$28.92
-$372,514.00
142.2K
Scheduled
Aug 24
Form 4
+23.44%
27K
—
—
142.2K
Aug 17
Form 4
—
0
$32.42
-$442,461.00
115.2K
Scheduled
Jul 27
Form 4
—
0
$37.15
-$537,158.00
115.2K
Scheduled
Jun 22
Form 4
+4.55%
5K
$10.29
$51,450.00
114.84K
Jan 25
Form 4
—
0
$38.92
-$431,420.66
109.84K
Scheduled
Nov 9
Form 4
-3.02%
-3.42K
$51.74
-$176,847.32
109.84K
Scheduled
Nov 1
Form 4
—
0
$33.52
-$104,488.54
113.25K
Scheduled
Sep 22
Form 4
+34.42%
29K
—
—
113.25K
Aug 27
Form 4
-4.52%
-3.99K
$46.59
-$185,943.48
84.25K
Scheduled
Aug 22
Form 4
+6.01%
5K
$10.29
$51,450.00
88.25K
Jun 2
Form 4
+23.13%
15.54K
$42.02
-$187,512.87
82.72K
Scheduled
Aug 20 - Aug 25
Form 4
+34.98%
17.23K
$43.55
-$120,717.83
66.48K
Scheduled
Aug 24 - Aug 26
Form 4
-2.49%
-1.24K
$53.25
-$66,083.25
48.67K
Scheduled
Feb 20
Form 4
-2.35%
-1.20K
$45.75
-$54,945.75
49.91K
Scheduled
Jan 16
Form 4
+18.83%
8.1K
—
—
51.11K
Oct 31
Form 3
—
0
—
—
0
No matching records found

Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03

Investor

Jonathan G Drachman owns 200,000 units of Common Stock which is worth $6,000.00. In the year 2014 Jonathan G Drachman acquired a total of 200,000 shares in Calithera Biosciences, Inc. at a cost of $171,900.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
200K
$0.86
$171,900.00
200K
Nov 10
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 9
Form 3
—
0
—
—
0
No matching records found

AQUINOX PHARMACEUTICALS, INC (NLTX) No price found

President and CEO

Jonathan G Drachman owns 2,348,686 units of Common Stock. Jonathan G Drachman used to own units in Series A Preferred Stock but no longer holds any shares there. In the year 2019 Jonathan G Drachman filed a total of 11 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 2
Form 4
+6.67%
150K
$6.34
$933,550.00
2.4M
Aug 24 - Aug 25
Form 4
—
0
—
—
0
Aug 3
Form 4
+2.27%
50K
$9.51
$475,354.00
2.25M
Jun 3 - Jun 4
Form 4
—
0
—
—
0
Aug 10
Form 4
+164.69%
1.37M
$8.40
$999,994.80
2.2M
Nov 12 - Dec 20
Form 4/A
∞
580.65K
—
—
580.65K
Aug 8
Form 4
+74.75%
250K
$3.13
$781,746.58
584.43K
Sep 9 - Sep 11
Form 4
—
0
—
—
0
Aug 31
Form 4
∞
341.86K
—
—
341.86K
Aug 8
Form 3
—
0
—
—
0
No matching records found

Harpoon Therapeutics, Inc. (HARP) No price found

Investor

Jonathan G Drachman used to own units in Common Stock but no longer holds any shares there. From 2019 to 2024 Jonathan G Drachman acquired a total of 5,415 shares in Harpoon Therapeutics, Inc., Jonathan also disposed a total of 5,415 shares of Harpoon Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-5.00K
—
—
0
Mar 8 - Mar 11
Form 4
∞
5K
—
—
5K
Nov 27
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 22
Form 4/A
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Feb 7
Form 3
—
0
—
—
0
No matching records found